Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

OVIDOVID
Showing 8 of 23 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in OVID THERAPEUTICS INC

Bank of New York Mellon Corp holds 416,318 shares of OVID (OVID THERAPEUTICS INC), worth $1.1M as of 2026-Q2. The position was increased (+656.4% shares). OVID represents 0.0% of Bank of New York Mellon Corp's portfolio.

Current Value

$1.1M

Current Shares

416,318

Total Value Change

+$924,297

Total Shares Change

+250,555

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
416,318
+656.4%
$1.1M0.0%$2.69
41
2026-Q1
Decreased
55,038
-4.6%
$122,1840.0%$1.70
0
2025-Q4
Unchanged
57,698
0.0%
$94,0480.0%$1.63
0
2025-Q3
Increased
57,698
0.0%
$75,0070.0%$1.40
14
2025-Q2
Decreased
57,697
-65.2%
$19,0340.0%$0.30
0
2025-Q1
Unchanged
165,763
0.0%
$51,7020.0%$0.35
0
2024-Q4
Unchanged
165,763
0.0%
$154,7740.0%$0.96
0
2024-Q3
Decreased
165,763
-24.0%
$195,6000.0%$1.18
0

Other major holders of OVID: BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., Janus Henderson Group Ltd., STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used